image
Healthcare - Medical - Devices - NYSE - US
$ 10.01
3.2 %
$ 836 M
Market Cap
-16.15
P/E
1. INTRINSIC VALUE

Paragon 28, Inc. designs, develops, distributes, and sells foot and ankle surgical systems in the United States and internationally. It offers plating systems, including gorilla plating systems, such as lisfranc, lapidus, lateral column, calcaneus slide, and naviculocuneiform (NC) fusion plating systems; baby gorilla plate-specific screws, navicular fracture plates, and 5th metatarsal hook plates; and silverback plating systems. The company also provides precision guide technology for various procedures consisting of fusion, a procedure to address bunion deformities that fuses two bones on the big toe; first tarsometatarsal arthrodesis; and metatarsal osteotomy for bunion correction, medial column beaming for charcot foot reconstruction, ankle fusion plating, and NC joint arthrodesis.[ Read More ]

The intrinsic value of one FNA stock under the base case scenario is HIDDEN Compared to the current market price of 10 USD, Paragon 28, Inc. is HIDDEN

2. FUNDAMENTAL ANALYSIS

Price Chart FNA

image
FINANCIALS
216 M REVENUE
19.30%
-37.3 M OPERATING INCOME
-6.45%
-47.8 M NET INCOME
28.94%
-63.9 M OPERATING CASH FLOW
-29.91%
-27 M INVESTING CASH FLOW
55.54%
129 M FINANCING CASH FLOW
225.81%
62.3 M REVENUE
2.16%
-8.45 M OPERATING INCOME
21.51%
-14.5 M NET INCOME
-5.23%
-2.65 M OPERATING CASH FLOW
74.12%
-3.84 M INVESTING CASH FLOW
-11.42%
133 K FINANCING CASH FLOW
-92.53%
Balance Sheet Decomposition Paragon 28, Inc.
image
Current Assets 216 M
Cash & Short-Term Investments 75.6 M
Receivables 38.1 M
Other Current Assets 102 M
Non-Current Assets 125 M
Long-Term Investments 0
PP&E 74.1 M
Other Non-Current Assets 50.8 M
Current Liabilities 51.2 M
Accounts Payable 21.7 M
Short-Term Debt 1.18 M
Other Current Liabilities 28.4 M
Non-Current Liabilities 112 M
Long-Term Debt 111 M
Other Non-Current Liabilities 868 K
EFFICIENCY
Earnings Waterfall Paragon 28, Inc.
image
Revenue 216 M
Cost Of Revenue 43.6 M
Gross Profit 173 M
Operating Expenses 210 M
Operating Income -37.3 M
Other Expenses 10.5 M
Net Income -47.8 M
RATIOS
79.85% GROSS MARGIN
79.85%
-17.24% OPERATING MARGIN
-17.24%
-22.11% NET MARGIN
-22.11%
-26.92% ROE
-26.92%
-14.04% ROA
-14.04%
-13.00% ROIC
-13.00%
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis Paragon 28, Inc.
image
Net Income -47.8 M
Depreciation & Amortization 15.5 M
Capital Expenditures -28 M
Stock-Based Compensation 12.4 M
Change in Working Capital -53 M
Others -13.9 M
Free Cash Flow -91.9 M
3. WALL STREET ANALYSTS ESTIMATES
Wall Street Analysts Price Targets Paragon 28, Inc.
image
Wall Street analysts predict an average 1-year price target for FNA of $13 , with forecasts ranging from a low of $11 to a high of $15 .
FNA Lowest Price Target Wall Street Target
11 USD 9.89%
FNA Average Price Target Wall Street Target
13 USD 29.87%
FNA Highest Price Target Wall Street Target
15 USD 49.85%
4. DIVIDEND ANALYSIS
0.00% DIVIDEND YIELD
0 USD DIVIDEND PER SHARE
5. COMPETITION
6. Ownership
Insider Ownership Paragon 28, Inc.
image
Sold
0-3 MONTHS
41.8 K USD 1
3-6 MONTHS
0 USD 0
6-9 MONTHS
0 USD 0
9-12 MONTHS
0 USD 0
Bought
0 USD 0
0-3 MONTHS
0 USD 0
3-6 MONTHS
255 K USD 1
6-9 MONTHS
0 USD 0
9-12 MONTHS
Date Value Insider Amount Avg Price
4 days ago
Nov 13, 2024
Sell 41.8 K USD
WRIGHT KRISTINA
Director
- 4181
10 USD
8 months ago
Mar 15, 2024
Bought 255 K USD
DaCosta Albert
See Remarks
+ 28000
9.1152 USD
1 year ago
Nov 10, 2023
Bought 260 K USD
DaCosta Albert
see remarks
+ 30500
8.51 USD
1 year ago
Jun 14, 2023
Sell 128 K USD
SCHNETTLER THOMAS P
Director
- 6900
18.5437 USD
1 year ago
Dec 01, 2022
Sell 51.2 K USD
Friedman Jonathan I
- 2500
20.5 USD
1 year ago
Nov 25, 2022
Sell 254 K USD
Friedman Jonathan I
- 12500
20.3451 USD
1 year ago
Jun 06, 2023
Sell 126 K USD
WRIGHT KRISTINA
Director
- 6800
18.5801 USD
1 year ago
Feb 17, 2023
Sell 3.44 M USD
Bird B. AG
10 percent owner
- 202500
17 USD
1 year ago
Feb 17, 2023
Sell 1.28 M USD
DaCosta Albert
See Remarks
- 75000
17 USD
1 year ago
Feb 17, 2023
Sell 1.28 M USD
DaCosta Albert
See Remarks
- 75000
17 USD
1 year ago
Jan 26, 2023
Sell 196 K USD
MVM Partners, LLC
10 percent owner
- 9597
20.4161 USD
1 year ago
Jan 30, 2023
Sell 23 M USD
Bird B. AG
10 percent owner
- 1350000
17 USD
1 year ago
Jan 30, 2023
Sell 8.5 M USD
DaCosta Albert
See Remarks
- 500000
17 USD
1 year ago
Jan 30, 2023
Sell 8.5 M USD
DaCosta Albert
See Remarks
- 500000
17 USD
1 year ago
Dec 23, 2022
Sell 735 K USD
Jarboe Matthew
Chief Commercial Officer
- 35110
20.9253 USD
1 year ago
Dec 21, 2022
Sell 521 K USD
Jarboe Matthew
Chief Commercial Officer
- 24913
20.9132 USD
1 year ago
Dec 19, 2022
Sell 196 K USD
MVM Partners LLP
Director
- 9597
20.4161 USD
1 year ago
Dec 13, 2022
Sell 30.6 K USD
MVM Partners LLP
Director
- 1510
20.2524 USD
1 year ago
Dec 14, 2022
Sell 218 K USD
MVM Partners LLP
Director
- 10668
20.4375 USD
1 year ago
Dec 08, 2022
Sell 582 K USD
MVM Partners LLP
Director
- 29000
20.0744 USD
1 year ago
Dec 08, 2022
Sell 268 K USD
MVM Partners LLP
Director
- 13273
20.2245 USD
1 year ago
Dec 09, 2022
Sell 37.9 K USD
MVM Partners LLP
Director
- 1873
20.2437 USD
1 year ago
Dec 01, 2022
Sell 585 K USD
DaCosta Albert
See Remarks
- 30000
19.5141 USD
1 year ago
Nov 30, 2022
Sell 117 K USD
MVM Partners LLP
Director
- 5829
20.1355 USD
1 year ago
Dec 01, 2022
Sell 20.1 K USD
MVM Partners LLP
Director
- 1000
20.1 USD
1 year ago
Dec 01, 2022
Sell 4.05 K USD
MVM Partners LLP
Director
- 200
20.23 USD
1 year ago
Nov 25, 2022
Sell 489 K USD
MVM Partners LLP
Director
- 24171
20.2306 USD
1 year ago
Nov 23, 2022
Sell 19.9 K USD
MVM Partners LLP
Director
- 987
20.13 USD
2 years ago
Nov 14, 2022
Sell 547 K USD
MVM Partners LLP
Director
- 27013
20.2601 USD
2 years ago
Nov 15, 2022
Sell 40.3 K USD
MVM Partners LLP
Director
- 2000
20.1672 USD
2 years ago
Nov 07, 2022
Sell 1.13 M USD
Rosenthal Lee
Director
- 61001
18.4824 USD
2 years ago
Oct 28, 2022
Sell 49 K USD
MVM Partners LLP
Director
- 2497
19.6423 USD
2 years ago
Oct 28, 2022
Sell 595 K USD
MVM Partners LLP
Director
- 30000
19.8228 USD
2 years ago
Oct 28, 2022
Sell 390 K USD
MVM Partners LLP
Director
- 20110
19.3723 USD
2 years ago
Oct 31, 2022
Sell 547 K USD
MVM Partners LLP
Director
- 27487
19.9075 USD
2 years ago
Aug 08, 2022
Sell 775 K USD
Rosenthal Lee
Director
- 39690
19.5341 USD
2 years ago
Aug 08, 2022
Sell 1.85 M USD
Rosenthal Lee
Director
- 95031
19.511 USD
2 years ago
Aug 10, 2022
Sell 3.02 M USD
Rosenthal Lee
Director
- 150609
20.0493 USD
2 years ago
Aug 10, 2022
Sell 2.37 M USD
Rosenthal Lee
Director
- 114775
20.6238 USD
2 years ago
Aug 11, 2022
Sell 1.02 M USD
Rosenthal Lee
Director
- 49498
20.6635 USD
2 years ago
Aug 11, 2022
Sell 253 K USD
Rosenthal Lee
Director
- 12030
21.0415 USD
2 years ago
Aug 15, 2022
Sell 1.31 M USD
Rosenthal Lee
Director
- 64519
20.3023 USD
2 years ago
Aug 16, 2022
Sell 52.6 K USD
Rosenthal Lee
Director
- 2615
20.1003 USD
2 years ago
Sep 12, 2022
Sell 489 K USD
Rosenthal Lee
Director
- 25674
19.0632 USD
2 years ago
Sep 14, 2022
Sell 111 K USD
Rosenthal Lee
Director
- 5836
19.0692 USD
2 years ago
Sep 15, 2022
Sell 42.1 K USD
Rosenthal Lee
Director
- 2200
19.1285 USD
2 years ago
Oct 04, 2022
Sell 82.6 K USD
Rosenthal Lee
Director
- 4328
19.0964 USD
2 years ago
Jul 20, 2022
Sell 798 K USD
Rosenthal Lee
Director
- 42865
18.6257 USD
2 years ago
Jul 21, 2022
Sell 1.08 M USD
Rosenthal Lee
Director
- 58171
18.4838 USD
2 years ago
Jul 21, 2022
Sell 514 K USD
Rosenthal Lee
Director
- 27838
18.4681 USD
2 years ago
Jul 25, 2022
Sell 386 K USD
Rosenthal Lee
Director
- 20813
18.5266 USD
2 years ago
Jul 25, 2022
Sell 690 K USD
Rosenthal Lee
Director
- 37292
18.5097 USD
2 years ago
Jul 27, 2022
Sell 896 K USD
Rosenthal Lee
Director
- 46113
19.4363 USD
2 years ago
Jul 28, 2022
Sell 1.95 K USD
Rosenthal Lee
Director
- 100
19.54 USD
2 years ago
Jul 28, 2022
Sell 96.7 K USD
Rosenthal Lee
Director
- 5080
19.0345 USD
2 years ago
Jul 29, 2022
Sell 24.5 K USD
Rosenthal Lee
Director
- 1290
19 USD
2 years ago
Aug 01, 2022
Sell 121 K USD
Rosenthal Lee
Director
- 6372
19.023 USD
2 years ago
Aug 03, 2022
Sell 1.42 M USD
Rosenthal Lee
Director
- 73408
19.3198 USD
2 years ago
Aug 04, 2022
Sell 781 K USD
Rosenthal Lee
Director
- 39937
19.5601 USD
2 years ago
Aug 05, 2022
Sell 2.34 M USD
Rosenthal Lee
Director
- 119466
19.5555 USD
2 years ago
Oct 26, 2022
Sell 176 K USD
MVM Partners LLP
Director
- 9156
19.1797 USD
2 years ago
Oct 27, 2022
Sell 14 K USD
MVM Partners LLP
Director
- 734
19.1376 USD
2 years ago
Oct 04, 2022
Sell 29 K USD
MVM Partners LLP
Director
- 1517
19.0936 USD
2 years ago
Sep 20, 2022
Sell 213 K USD
MVM Partners LLP
10 percent owner
- 11485
18.5202 USD
2 years ago
Sep 21, 2022
Sell 311 K USD
MVM Partners LLP
10 percent owner
- 16735
18.6015 USD
2 years ago
Sep 21, 2022
Sell 155 K USD
MVM Partners LLP
10 percent owner
- 8201
18.9277 USD
2 years ago
Sep 15, 2022
Sell 115 K USD
MVM Partners LLP
10 percent owner
- 6043
19.0461 USD
2 years ago
Sep 16, 2022
Sell 33 K USD
MVM Partners LLP
10 percent owner
- 1780
18.5396 USD
2 years ago
Sep 13, 2022
Sell 10.9 K USD
MVM Partners LLP
10 percent owner
- 575
18.9257 USD
2 years ago
Sep 14, 2022
Sell 269 K USD
MVM Partners LLP
10 percent owner
- 14101
19.079 USD
2 years ago
Sep 14, 2022
Sell 564 K USD
MVM Partners LLP
10 percent owner
- 30000
18.8117 USD
2 years ago
Sep 14, 2022
Sell 154 K USD
MVM Partners LLP
10 percent owner
- 8134
18.9235 USD
2 years ago
Sep 09, 2022
Sell 546 K USD
MVM Partners LLP
10 percent owner
- 29200
18.7139 USD
2 years ago
Sep 12, 2022
Sell 15.1 K USD
MVM Partners LLP
10 percent owner
- 800
18.8838 USD
2 years ago
Sep 12, 2022
Sell 975 K USD
MVM Partners LLP
10 percent owner
- 51231
19.0401 USD
2 years ago
Sep 08, 2022
Sell 540 K USD
DaCosta Albert
See Remarks
- 30000
18.0069 USD
2 years ago
Aug 26, 2022
Sell 15 K USD
MVM Partners LLP
director:
- 800
18.7775 USD
2 years ago
Aug 24, 2022
Sell 331 K USD
MVM Partners LLP
director:
- 17876
18.5388 USD
2 years ago
Aug 15, 2022
Sell 46 K USD
MVM Partners LLP
director:
- 2301
19.9704 USD
2 years ago
Aug 11, 2022
Sell 584 K USD
Jarboe Matthew
Chief Commercial Officer
- 27878
20.937 USD
2 years ago
Aug 10, 2022
Sell 709 K USD
MVM Partners LLP
director:
- 34099
20.7782 USD
2 years ago
Aug 08, 2022
Sell 357 K USD
MVM Partners LLP
director:
- 18303
19.4787 USD
2 years ago
Aug 04, 2022
Sell 475 K USD
MVM Partners LLP
director:
- 25000
18.9976 USD
2 years ago
Jul 14, 2022
Sell 260 K USD
Jarboe Matthew
Chief Commercial Officer
- 13679
19.0024 USD
2 years ago
Jul 08, 2022
Sell 1.24 M USD
Jarboe Matthew
Chief Commercial Officer
- 63889
19.4433 USD
2 years ago
Jun 06, 2022
Sell 115 K USD
Bono Frank S.
Chief Technology Officer
- 6322
18.1548 USD
2 years ago
May 27, 2022
Sell 435 K USD
Bono Frank S.
Chief Technology Officer
- 24155
17.99 USD
7. News
SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Paragon 28, Inc. - FNA NEW YORK, NY / ACCESSWIRE / November 16, 2024 / Pomerantz LLP announces that a class action lawsuit has been filed against Paragon 28, Inc. ("Paragon 28" or the "Company") (NYSE:FNA). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. accesswire.com - 15 hours ago
FNA DEADLINE: ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Paragon 28, Inc. Investors With Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – FNA NEW YORK, Nov. 16, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Paragon 28, Inc. (NYSE: FNA) between May 5, 2023 and September 20, 2024, both dates inclusive (the “Class Period”), and those who purchased Paragon 28 call options or sold put options during the Class Period, of the November 29, 2024 lead plaintiff deadline in the securities class action first filed by the Firm. globenewswire.com - 1 day ago
November 29, 2024 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against FNA NEW YORK, NY / ACCESSWIRE / November 15, 2024 / If you suffered a loss on your Paragon 28, Inc. (NYSE:FNA) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/paragon-28-inc-lawsuit-submission-form?prid=112184&wire=1 or contact Joseph E. Levi, Esq. accesswire.com - 1 day ago
Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Paragon 28, Inc. (FNA) LOS ANGELES, Nov. 15, 2024 (GLOBE NEWSWIRE) -- Glancy Prongay & Murray LLP (“GPM”) reminds investors of the upcoming November 29, 2024 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Paragon 28, Inc. (“Paragon” or the “Company”) (NYSE: FNA ) common stock between May 5, 2023 and September 20 , 2024, inclusive (the “Class Period”). globenewswire.com - 1 day ago
Lost Money on Paragon 28, Inc.(FNA)? Join Class Action Suit Seeking Recovery – Contact Levi & Korsinsky NEW YORK, NY / ACCESSWIRE / November 15, 2024 / If you suffered a loss on your Paragon 28, Inc. (NYSE:FNA) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/paragon-28-inc-lawsuit-submission-form?prid=112175&wire=1 or contact Joseph E. Levi, Esq. accesswire.com - 1 day ago
Paragon 28, Inc. Securities Fraud Lawsuit Pending WASHINGTON, DC / ACCESSWIRE / November 15, 2024 / Cohen Milstein alerts investors that a complaint was filed on October 18, 2024 in the U.S. District Court for the District of Colorado against medical device company Paragon 28, Inc. ("Paragon 28" or the "Company). The complaint alleges that certain current and former officers made false and misleading statements to investors about financial statements and internal controls in violation of Sections 10(b) and 20(a) of the Securities Exchange Act of 1934. accesswire.com - 1 day ago
How Much Upside is Left in Paragon 28, Inc. (FNA)? Wall Street Analysts Think 52.58% The consensus price target hints at a 52.6% upside potential for Paragon 28, Inc. (FNA). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term. zacks.com - 1 day ago
Investors who lost Money on Paragon 28, Inc. (FNA) should contact Levi & Korsinsky about Pending Class Action - FNA NEW YORK, NY / ACCESSWIRE / November 15, 2024 / If you suffered a loss on your Paragon 28, Inc. (NYSE:FNA) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/paragon-28-inc-lawsuit-submission-form?prid=112126&wire=1 or contact Joseph E. Levi, Esq. accesswire.com - 1 day ago
Paragon 28, Inc. Is Being Sued For Violating Securities Laws And The Schall Law Firm Urges Affected Investors To Reach Out LOS ANGELES, CA / ACCESSWIRE / November 15, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Paragon 28, Inc. ("Paragon 28" or "the Company") (NYSE:FNA) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between May 5, 2023 and August 8, 2024, inclusive (the "Class Period"), are encouraged to contact the firm before November 29, 2024. accesswire.com - 1 day ago
Investors who lost money on Paragon 28, Inc. (FNA) should contact Levi & Korsinsky about pending Class Action - FNA NEW YORK, NY / ACCESSWIRE / November 15, 2024 / If you suffered a loss on your Paragon 28, Inc. (NYSE:FNA) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/paragon-28-inc-lawsuit-submission-form?prid=112069&wire=1 or contact Joseph E. Levi, Esq. accesswire.com - 1 day ago
FNA Shareholders Have Opportunity to Lead Paragon 28, Inc. Class Action Lawsuit - Contact Bronstein, Gewirtz and Grossman, LLC Today! NEW YORK CITY, NY / ACCESSWIRE / November 15, 2024 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Paragon 28, Inc. ("Paragon 28" or "the Company") (NYSE:FNA) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Paragon 28 securities between May 5, 2023 through September 20, 2024, inclusive (the "Class Period"). accesswire.com - 1 day ago
Class Action Filed Against Paragon 28, Inc. (FNA) Seeking Recovery for Investors - Contact Levi & Korsinsky NEW YORK , Nov. 15, 2024 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Paragon 28, Inc. ("Paragon 28, Inc." or the "Company") (NYSE: FNA) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Paragon 28, Inc. investors who were adversely affected by alleged securities fraud between May 5, 2023 and September 20, 2024. prnewswire.com - 1 day ago
8. Profile Summary

Paragon 28, Inc. FNA

image
COUNTRY US
INDUSTRY Medical - Devices
MARKET CAP $ 836 M
Dividend Yield 0.00%
Description Paragon 28, Inc. designs, develops, distributes, and sells foot and ankle surgical systems in the United States and internationally. It offers plating systems, including gorilla plating systems, such as lisfranc, lapidus, lateral column, calcaneus slide, and naviculocuneiform (NC) fusion plating systems; baby gorilla plate-specific screws, navicular fracture plates, and 5th metatarsal hook plates; and silverback plating systems. The company also provides precision guide technology for various procedures consisting of fusion, a procedure to address bunion deformities that fuses two bones on the big toe; first tarsometatarsal arthrodesis; and metatarsal osteotomy for bunion correction, medial column beaming for charcot foot reconstruction, ankle fusion plating, and NC joint arthrodesis. In addition, it offers monster, mini monster, and joust beaming screw systems for use in bone reconstruction, osteotomy, arthrodesis, joint fusion, ligament fixation, fracture repair, and fracture fixation; and APEX 3D total ankle replacement systems; total talus spacers to replace the talus and bone in the ankle that connects the leg and foot. Further, the company provides bunion or hallux valgus correction systems, including nail systems phantom intramedullary nail systems for the treatment of severe hallux valgus; and various orthobiologics comprising bone wedges, grafts, demineralized bone matrices, bone void fillers, synthetic materials, amniotic products, and a biocompatible collagen matrix, as well as PRESERVE bone graft systems for homologous application. Additionally, it offers soft tissue fixation systems, titanium sprayed polyetheretherketone implants, nitinol staple systems, stabilization systems, and curved instruments. The company serves hospitals and ambulatory surgery centers through a network of sales representatives and stocking distributors. Paragon 28, Inc. was founded in 2010 and is headquartered in Englewood, Colorado.
Contact 14445 Grasslands Drive, Englewood, CO, 80112 https://www.paragon28.com
IPO Date Oct. 15, 2021
Employees 574
Officers Mr. Chadi Chahine Chief Financial Officer & Executive Vice President of Supply Chain Operations Mr. Brendan Shook Executive Vice President of Marketing & Medical Education Dr. Matthew Millard Chief Human Resources Officer Mr. Robert S. McCormack J.D. General Counsel & Secretary Mr. Matthew Jarboe Executive Vice President of Sales & Chief Commercial Officer Mr. Andrew James Hill Executive Vice President of Research & Development Mr. Matthew Brinckman Senior Vice President of Strategy & Investor Relations Mr. Hans Kestler Executive Vice President of International Mr. Albert DaCosta Co-Founder, Chairman, President & Chief Executive Officer Mr. John Shumaker Executive Vice President of Sales - U.S.